Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 4 | 1 |
| List of Figures | 4 | 1 |
| Introduction | 5 | 1 |
| Global Markets Direct Report Coverage | 5 | 1 |
| Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) Overview | 6 | 1 |
| Therapeutics Development | 7 | 3 |
| Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) Products under Development by Stage of Development | 7 | 1 |
| Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) Products under Development by Therapy Area | 8 | 1 |
| Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) Products under Development by Indication | 9 | 1 |
| Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) Pipeline Products Glance | 10 | 1 |
| Early Stage Products | 10 | 1 |
| Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) Products under Development by Companies | 11 | 2 |
| Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) Products under Development by Universities/Institutes | 13 | 2 |
| Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) Therapeutics Assessment | 15 | 5 |
| Assessment by Monotherapy/Combination Products | 15 | 1 |
| Assessment by Mechanism of Action | 16 | 1 |
| Assessment by Route of Administration | 17 | 1 |
| Assessment by Molecule Type | 18 | 2 |
| Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) Companies Involved in Therapeutics Development | 20 | 5 |
| ALSP, Inc. | 20 | 1 |
| BioMAS Ltd. | 21 | 1 |
| Oncomatryx Biopharma, S.L. | 22 | 1 |
| Phelix Therapeutics, LLC | 23 | 1 |
| Virobay Inc. | 24 | 1 |
| Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) Drug Profiles | 25 | 12 |
| ALP-496 Drug Profile | 25 | 2 |
| CIBP-4 Drug Profile | 27 | 1 |
| Drugs to Inhibit Cathepsin B for Ebola Viral Infections Drug Profile | 28 | 1 |
| OMTX-001 Drug Profile | 29 | 1 |
| SAS Drug Profile | 30 | 1 |
| Small Molecule to Inhibit Cathepsin B for Oncology Drug Profile | 31 | 1 |
| Small Molecules to Activate Cathepsin B for Alzheimer's Disease Drug Profile | 32 | 1 |
| VBY-129 Drug Profile | 33 | 1 |
| VBY-285 Drug Profile | 34 | 1 |
| VBY-376 Drug Profile | 35 | 1 |
| VBY-825 Drug Profile | 36 | 1 |
| Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) Dormant Projects | 37 | 1 |
| Cathepsin B (APP Secretase or Cathepsin B1 or EC 3.4.22.1) Featured News &Press Releases | 38 | 2 |
| Apr 19, 2016: American Life Science Pharmaceuticals Obtains Patent | 38 | 1 |
| Jan 25, 2016: ALSP invited to Give Oral Presentation at the Keystone TBI Conference January 25-27 in Santa Fe, New Mexico | 38 | 1 |
| Nov 14, 2011: Virobay's Spectrum-Selective Cathepsin Inhibitor Shows Efficacy In Bone Cancer Model | 38 | 2 |
| Appendix | 40 | 2 |
| Methodology | 40 | 1 |
| Coverage | 40 | 1 |
| Secondary Research | 40 | 1 |
| Primary Research | 40 | 1 |
| Expert Panel Validation | 40 | 1 |
| Contact Us | 40 | 1 |
| Disclaimer | 41 | 1 |